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Some  species  of the  Clusia  genus  have  been  shown  to  have  important  biomedical  properties,  including
the  ability  to inhibit  tumor  growth  in  vitro  and  the usefulness  for skin  care.  In this  study,  we  exam-
ined  the  cytotoxic  effect  of hexane,  ethyl  acetate  and  methanol  extracts  from  Clusia  latipes  Planch.  &
Triana,  Clusiaceae,  leaves  on  survival  of human  prostate  cancer  cells  (PC-3),  colon  cancer  cells  (RKO),
astrocytoma  cells  (D-384),  and  breast  cancer  cells  (MCF-7).  The  ethyl  acetate  extract  displayed  the  most
substantial  cytotoxic  effect.  However,  using  a Comet  assay,  we observed  that  the  hexane  extract  induced
a  genotoxic  effect  (DNA  damage)  on  human  lymphocytes  in  an  in vitro  model.  Chromatographic  puriﬁ-ytotoxicity
enotoxicity
omet assay
cation  of  the C.  latipes  hexane  extract  led  to the isolation  and  identiﬁcation  of  friedelin,  friedolan-3-ol,
and  hesperidin  as active  cytotoxic  compounds  in  hexane  extract,  while  -amyrine  was identiﬁed  as  an
active cytotoxic  compound  in  the  ethyl  acetate  extract of C. latipes,  thereby  supporting  further  stud-
ies  of the  molecular  mechanisms  underlying  the effect  of these  secondary  metabolites  on  cancer  cell
survival.
© 2015  Sociedade  Brasileira  de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
The Clusiaceae family, also known as Guttiferae, consists of trop-
cal plants and includes approximately 27 genera and 1090 species
Stevens, 2007). The ﬂora of Southern Ecuador includes a large
umber of species that belong to the family Clusiaceae. The most
epresentative and important genus is Clusia,  which is known for its
seful biomedical properties. The species of this genus have various
iological activities, demonstrating their role as a promising source
f active biomedical phytocompounds/phytometabolites that can
e used for antimicrobial (Suffredini et al., 2006), anticancer (Díaz-
arballo et al., 2012; Monks et al., 2002), antioxidant (Ferreira
t al., 2014), anti-inﬂammatory, and antihepatotoxic activities.
urthermore, members of the Clusia family have been shown to
ave an inhibitory effect on human immunodeﬁciency virus (HIV)
Huerta-Reyes et al., 2004; Balunas and Kinghorn, 2005). The most
∗ Corresponding author.
E-mail: ostrosky@biomedicas.unam.mx (P. Ostrosky-Wegman).
http://dx.doi.org/10.1016/j.bjp.2015.08.014
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editoraprominent biomedical applications of these species include the
treatment of leprosy and headaches, treatment of warts, and the
control of obesity (Hemshekhar et al., 2011). Leaves of Clusia sp.
are often used to soften the skin and have a potential beneﬁt
in skin care (Valadeau et al., 2010). Because this genus presents
great variability in terms of biological activities, it presents an
interesting source of active secondary metabolites to be used
for their potential antitumor activities. In the present study, we
performed a chemical composition analysis of the active phy-
tometabolites obtained from organic extracts of the leaves of Clusia
latipes, as well as an evaluation of the cytotoxic and genotoxic
activities of these extracts on human cancer cell lines and human
lymphocytes.
Materials and methodsPlant material
A total of 10.6 kg of leaves and stems of Clusia latipes Planch.
& Triana, Clusiaceae, were collected in Gonzanama-Quilanga
 Ltda. All rights reserved.
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0◦57′46′′ Lat. S, 77◦11′46′′ Long. O, 2300 m.a.s.l.) region of the
oja Province of Ecuador. A sample specimen (PPN-Cl 002) was
eposited and identiﬁed in the Herbarium of Departamento de
uímica of the Universidad Técnica Particular of Loja, Ecuador.
lant material was dried at 30 ◦C for seven days in dryer trays with
ir ﬂow, and then was reduced to ﬁne particles by manual grinding
o a suitable size.
reparation of extracts
The dried and ground leaves (1540 g) were macerated at room
emperature, with hexane (C. latipes Hex), ethyl acetate (C. latipes
tOAc), and methanol (C. latipes MeOH) sequentially for three days
ith three liter of each solvent, the procedure was  repeated three
imes. The extract were ﬁltered using ﬁlter paper, all extracts were
oncentrated under reduced pressure, and subsequently stored at
oom temperature and protected from light until further use. For
iological studies, stock solutions (1000 g/ml) were prepared in
imethylsulfoxide (DMSO) and stored at −20 ◦C. The aliquots were
iluted to obtain the appropriate concentrations before use.
solation of secondary metabolites
To separate the components from the C. latipes extracts: Hex
39 g), EtOAc (28 g) and MeOH (50 g), and a silica gel-60 F254
hromatography column (CC, Merck) were used. Mixtures of these
hree solvents were used in polarity up to starting with hexane
100%) to obtain the compound separation. Fractions of 200 ml
ach were collected using a vacuum pump, the solvent was then
emoved on a rotary evaporator and the residue was  recovered with
ichloromethane. Thin layer chromatography (TLC) was performed
n each fraction for detection of the compounds. Compounds were
isualized by spraying with ceric sulfate solution in acid sulfuric
ollowed by heating on a hot plate. Fractions with a similar pro-
le were pooled and puriﬁed by conventional procedures: solvents
air technique and micro columns.
The hexane extract (39 g) was submitted to column chromatog-
aphy eluted with mixtures of three solvents Hex, EtOAc and MeOH
ere used in polarity up to starting with hexane (100%) to obtain
he compound separation, resulting in 428 fractions of 200 ml  each.
he eluted fractions were evaluated and pooled according to TLC
nalysis, affording 108 fractions (F-1 to F-108). F-13 was presented
s a yellow amorphous material submitted to recrystallization with
ethanol, obtaining in the end of the process a white amorphous
olid, which was identiﬁed as friedelin (1). The fraction F-32 eluted
ith Hex:EtOAc 80:20 (v/v), was present as an amorphous solid,
t was recrystallized with methanol, identiﬁed as friedolan 3-ol
2). The fraction F-72 were fractioned by silica gel-60 F254 chro-
atography column at 1:10 compound: silica gel and EtOAc:MeOH
80:20) as eluent, resulting a yellow amorphous solid identiﬁed as
esperidin (3). From the extract using EtOAc (28 g), 309 fractions
ere obtained. The eluted fractions were evaluated and pooled
ccording to TLC analysis, affording 90 fractions (F-1 to F-90),
rom fraction F-18, eluted with Hex:EtOAc 90:10 (v/v) a amor-
hous solid was presented, it was recrystallized with methanol
btaining in the end of the process a white amorphous solid,
hich was identiﬁed as -amyrine (4). From the MeOH extract
50 g), 478 fractions were obtained, the eluted fractions were eval-
ated and pooled according to TLC analysis, affording 127 fractions
F-1 to F-127), no pure compound was obtained from the this
xtract.haracterization and identiﬁcation of secondary metabolites
Melting points were determined using a Fisher Johns appara-
us. The 1H and 13C NMR  spectra were recorded at 400 MHz  and de Farmacognosia 26 (2016) 44–49 45
100 MHz, respectively, on a Varian 400 MHz-Premium Schelded
equipment using tetramethylsilane as an internal reference. CDCl3
and DMSO-d6 were used as solvents; chemical shifts were
expressed in parts per million (ppm) and coupling constants (J)
were reported in (Hz). Mass spectra (MS) were determined by a gas
chromatograph (Agilent Technologies 6890 N) coupled to a mass
spectrometer (Agilent Technologies 5973 inert).
Cell culture procedures
Four human cancer cell lines were used: PC-3 (prostate
cancer), RKO (colon cancer), D-384 (astrocytoma), and MCF-7
(breast cancer). The cells were cultured in RPMI-1640 medium
supplemented with 10% fetal bovine serum (FBS, Invitrogen),
1% antibiotic-antimitotic solution (100 units/ml penicillin G,
100 g/ml streptomycin, 0.25 g/ml amphotericin B, Gibco), and
1% l-glutamine (2 mM,  Gibco). The cells were incubated at 37 ◦C,
5% CO2. Viable cells were counted using the trypan blue exclusion
method in a hemocytometer.
Cell viability analysis by MTS assay
The MTS  cell viability assay was used to assess the inhibitory
effects of the extracts on the survival of human cancer cell lines.
A total of 3–5 × 103 cells/well were seeded into 96-well plates and
were allowed to adhere for 24 h. The cells were then treated with
50 g/ml of whole extract, at ﬁnal volume of 2 ml. Each concen-
tration/assay was  performed three times. DMSO was  used as a
negative control at a ﬁnal concentration of 0.1% (v/v) and 1 M
doxorubicin was  used as a positive control. The cells were incubated
with the treatments for 48 h, after which 20 l MTS  (5 mg/ml, Aque-
ous One Solution Reagent, GIBCO) was  added and further incubated
for 4 h at 37 ◦C. The absorbance was  measured at 570 nm. The data
obtained with cells treated with DMSO were considered as 100% of
viability.
Determination of genotoxicity by Comet assay
Whole peripheral blood samples were obtained from three
healthy male donors (age range 20–25 years). Heparinized blood
samples (20 l) were cultured at 37 ◦C in RPMI-1640 medium (1 ml,
Gibco) supplemented with 1% l-glutamine (2 mM), and 1% non-
essential amino acids (10 mM,  Gibco), and were treated with three
different concentrations of C. latipes Hex extract (25, 35, 50 g/ml).
DMSO (0.5%) and ethyl methane sulfonate (EMS 0.1 M,  Sigma
chemical) were used as negative and positive controls, respec-
tively. The cells were treated for 3 h at 37 ◦C. Aliquots of 50 l of
each sample were used to determine the percentage of viable cells
using double staining with ﬂuorescein diacetate-ethidium bromide
(FDA/EtBr), counting a total of 200 cells (live-green, red-dead). A
Comet assay was  performed, as described by Sordo et al. (2001),
with minor modiﬁcations. The treated cells were centrifuged and
resuspended with 150 l low melting point agarose gel (LMPA, 1%).
Then, 75 l of the mixture was placed in duplicate onto a slides
previously covered with 150 l of agarose gel and immediately
covered with a coverslip to make a microgel on the slide. Slides
were placed in an ice-cold steel tray on ice for 1 min  to allow the
agarose to solidify. The coverslip was  removed, and 75 l of LMP
(1%) was layered as before. Slides were immersed in an ice-cold
lysing solution (2.5 M NaCl, 100 mM Na2EDTA, and 10 mM Tris-
base, pH 10). After lysis at 4 ◦C for 1 h, slides were subjected to
horizontal electrophoresis. The DNA was denatured for 20 min  in
electrophoresis running buffer solution (300 mM NaOH and 1 mM
Na2EDTA, pH >13.0). Electrophoresis was conducted for 20 min  at
25 V and 300 mA  (0.8 V/cm). All technical steps were conducted
using very dim indirect light. After electrophoresis, the slides were
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ently removed and alkaline pH was neutralized with 0.4 M Tris, pH
.5. The slides were dehydrated in two steps with absolute ethanol
or 1 min  each. Ethidium bromide (25 l of a 20 mg/ml solution)
as added to each slide and a coverslip was placed on the gel.
NA migration was analyzed on a Zeiss Axioskop 2 plus microscope
ith ﬂuorescence equipment (excitation ﬁlter 549 nm,  barrier ﬁl-
er 590 nm), and the tail length was measured with a scaled ocular.
or the evaluation of DNA migration, 100 cells were scored for each
ample at 40× magniﬁcation.
tatistical analysis
All data are reported as mean ± SEM of three independent exper-
ments. The statistical signiﬁcance was determined using one-way
nalysis of variance (ANOVA) followed by Dunnet post-test (Graph-
ad Prism 4). Comet data were analyzed using the Kruskal–Wallis
nd Dunn’s multiple comparison post-test (GraphPad Prism 4).
 < 0.05 was considered to be statistically signiﬁcant.
esults
solation of secondary metabolites from C. latipes leaves
Three extractions were conducted from the of C. latipes leaves:
1) Hex, (2) EtOAc and (3) MeOH, and four secondary metabo-
ites were isolated and characterized. From the Hex extract, 108
ractions were obtained and three compounds were identiﬁed.
rom the fraction F-13 eluted with Hex:EtOAc (95:5), 36 mg  of
 white amorphous solid was isolated and identiﬁed as friedelin
1). From the fraction F-32 eluted with Hex:EtOAc (80:20), 22 mg
f a solid was isolated and identiﬁed as friedolan 3-ol (2). From
he fraction F-72 eluted with EtOAc:MeOH (80:20), 17 mg  of yel-
ow amorphous solid was isolated and identiﬁed as hesperidin
3). From the extract using EtOAc, 90 fractions were obtained.
nly from fraction F-18, eluted with Hex:EtOAc (90:10), 8 mg
f a solid was isolated and identiﬁed as -amyrine (4). Any
ure compound was obtained from the MeOH extract. All the
ompounds were identiﬁed based on physical and spectroscopic
ata, by comparison with the literature (Quintans et al., 2014;
ubhadhirasakul and Pechpongs, 2005; Aghel et al., 2008; Gao et al.,
009).
haracterization and identiﬁcation of secondary metabolites
Physical and spectroscopic constants from friedelin (1): m.p.
35–239 ◦C. EIMS m/z (%): 426 (M+, 38), 411 (12), 341 (7), 302 (16),
73 (31), 205 (27), 69 (100). 1H NMR  (400 MHz, CDCl3): ı ppm: 0.66
s, 2H), 0.78–0.98 (m,  15H), 1.11–1.35 (m,  17H), 1.37–1.58 (m,  8H),
.66–1.71 (m,  1H), 1.79–2.03 (m,  2H), 2.10–2.38 (m,  3H) 7.19 (s, 1H).
able 1
ffect of Clusia latipes extracts in the growth of human cancer cell lines.
Treatment (50 g/ml) 
D384 (Astrocytoma) PC-3 (Prostate
Clusia latipes Hex 29.3 ± 4.8 1.8 ± 4.7 
Clusia  latipes AcOEt 33.5 ± 2.7 44.6 ± 3.8 
Clusia  latipes MeOH 24.7 ± 4.0 41.2 ± 3.4 
Doxorubicin 2 M 77.8 ± 1.5 70.9 ± 3.3 
a Mean and standard error (SEM) of at least three independent experiments. Control ce de Farmacognosia 26 (2016) 44–49
13C NMR  (100 MHz, CDCl3): ı ppm: 13C NMR (100 MHz, CDCl3): ı
ppm: 22.3 (C-1), 41.5 (C-2), 213.4 (C-3), 58.2 (C-4), 42.1 (C-5), 41.3
(C-6), 18.3 (C-7), 53.1 (C-8), 37.5 (C-9), 59.4 (C-10), 35.6 (C-11), 30.5
(C-12), 39.7 (C-13), 38.2 (C-14), 32.4 (C-15), 36.0 (C-16), 29.9 (C-17),
42.8 (C-18), 35.3 (C-19), 28.1 (C-20), 32.7 (C-21), 39.2 (C-22), 6.9 (C-
23), 14.8 (C-24), 17.9 (C-25), 20.4 (C-26), 18.8 (C-27), 32.1 (C-28),
35.0 (C-29), 31.7 (C-30).
Physical and spectroscopic constants from friedolan 3-ol (2):
m.p. 238–241 ◦C. EIMS m/z (%): 428 (M+, 20), 413 (27), 395 (7), 341
(3), 304 (2), 275 (23), 207 (11), 69 (100). 1H NMR  (400 MHz, CDCl3):
ı ppm: 3.72 (1H, bd, J = 3.1 Hz, H-3), 1.86 (1H, dt, J = 10.1, 3.0 Hz, H-
2a), 1.70 (1H, dt, J = 12.8, 3.1 Hz, H-6a), 1.57 (1H, m,  H-2b), 1.16 (3H,
s, H-28), 0.99 (3H, s, H-29), 0.97 (6H, s, H-26 and H-27), 0.95 (3H,
s, H-30), 0.94 (3H, d, J = 7.0 Hz, H-23), 0.93 (3H, s, H-24), 0.84 (3H,
s, H-25). 13C NMR  (100 MHz, CDCl3): ı ppm: 15.8 (C-1), 35.1 (C-2),
72.3 (C-3), 49.2 (C-4), 37.1 (C-5), 41.7 (C-6), 17.9 (C-7), 53.3 (C-8),
37.8 (C-9), 60.2 (C-10), 35.2 (C-11), 30.6 (C-12), 39.4 (C-13), 39.8
(C-14), 32.9 (C-15), 36.1 (C-16), 30.0 (C-17), 42.9 (C-18), 36.2 (C-
19), 28.3 (C-20), 32.1 (C-21), 39.3 (C-22), 11.6 (C-23), 16.4 (C-24),
18.2 (C-25), 18.8 (C-26), 20.1 (C-27), 32.3 (C-28), 35.0 (C-29), 31.9
(C-30).
Physical and spectroscopic constants from hesperidin (3): m.p.
258–259 ◦C. 1H NMR  (400 MHz, DMSO-d6) ı ppm: 1.08 (3H, d,
J = 6.0, H-6′′ ′), 2.77 (1H, dd, J = 3.11, 15.11, H-3eq), 3.07 (1H, dd,
J = 13.8, 12.0, H-3ax), 3.09–3.86 (2H, m,  H-2′′-H-5′′ ′), 3.77 (3H, s,
4′-OCH3), 4.52 (1H, d, J = 7.8, H-1′′), 4.97 (1H, s, H-1′′ ′), 5.49 (1H,
dd, J = 3.11, 15.11, H-2), 6.12 (1H, sl, H-8), 6.15 (1H, sl, H-6), 6.92
(3H, m,  H-2′, H-5′, H-6′), 12.06 (1H, s, 5-OH), 13C NMR  (100 MHz,
DMSO-d6) ı ppm: 78.4 (C-2), 42.1 (C-3), 197.0 (C-4), 163.1 (C-5),
96.4 (C-6), 165.2 (C-7), 95.6 (C-8), 162.5 (C-9), 103.3 (C-10), 130.9
(C-1′), 114.2 (C-2′), 146.5 (C-3′), 147.9 (C-4′), 112.0 (C-5′), 117.9 (C-
6′), 100.6 (C-1′′), 73.0 (C-2′′), 76.3 (C-3′′), 69.6 (C-4′′), 75.5 (C-5′′),
66.1 (C-6′′), 99.5 (C-1′′ ′), 70.3 (C-2′′ ′), 70.7 (C-3′′ ′), 72.1 (C-4′′ ′), 68.3
(C-5′′ ′), 17.8 (C-6′′ ′), 55.7 (4′-OCH3).
Physical and spectroscopic constants from -amyrine (4) m.p:
238–241 ◦C. EIMS m/z (%): 426 (M+, 51), 411 (20), 341 (10), 287
(13), 273 (61), 246 (33), 220 (18), 205 (57), 161 (29), 125 (85), 95
(100), 69 (97), 55 (56), 41 (30). 1H NMR  (400 MHz, CDCl3): ı ppm:
0.68 (1H, d, J = 11.0), 0.73 (1H, s), 0.77 (1H, s), 0.80 (1H, s), 0.87 (1H,
s), 0.90 (1H, s), 0.93 (1H, s), 1.07 (1H, s), 1.19 (1H, s), 1.70 (1H, td,
J = 4.3, 13.5 Hß), 1.8 (1H, m),  1.89 (1H, td, J = 4.0, 14.0 Hß), 1.93 (1H,
dd, J = 4.0, 13.7 Hß), 3.15 (1H, dd, J = 4.4, 10.8 Hz, H-3), 5.12 (1H, t,
J = 3.2). 13C NMR  (100 MHz, CDCl3): ı ppm: 38.7 (C-1), 27.2 (C-2),
79.3 (C-3), 38.5 (C-4), 55.1 (C-5), 18.6 (C-6), 32.4 (C-7), 39.8 (C-8),
47.6 (C-9), 36.9 (C-10), 23.6 (C-11), 121.7 (C-12), 145.2 (C-13), 41.7
(C-14), 26.2 (C-15), 26.1 (C-16), 32.6 (C-17), 47.2 (C-18), 46.8 (C-
19), 31.0 (C-20), 34.6 (C-21), 37.2 (C-22), 28.1 (C-23), 15.3 (C-24),
15.3 (C-25), 16.7 (C-26), 25.7 (C-27), 28.5 (C-28), 33.8 (C-29), 23.7
(C-30).% of inhibition ± SEMa
Human cancer cell lines
 cancer) MCF-7 (Breast cancer) RKO (Colon cancer)
27.2 ± 5.8 25.4 ± 6.2
33.7 ± 3.6 31.9 ± 6.4
9.5 ± 3.7 19.3 ± 4.1
75.9 ± 2.1 88.2 ± 1.3
lls were considered as 100% viability.
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ytotoxic effect of whole extracts on human cancer cell lines
The effect of secondary metabolites on cell viability was deter-
ined by an MTS  assay using human cancer cell lines treated for
8 h with whole extracts of C. latipes (50 g/ml). Nearly all of the
ested extracts inhibited the viability of the cancer cell lines by up
o 25% (Table 1). However, the Hex extract was unable to inhibit the
iability of the PC-3 prostate cancer cell line (1.8%), and the MeOH
xtract showed a low inhibitory effect on MCF-7 cells (∼9.5%), while
t decreased the viability of the PC-3 prostate cancer cells by ∼40%.
he EtOAc extract was shown to be the most active in decreasing
iability of all cancer cell lines (by more than 30%), and was  more
ffective on the PC-3 prostate cancer cell line (∼44%).
enotoxic effect of Hex extract in human lymphocytes
In the present study, the Hex extract was selected to evaluate
enotoxicity because it has molecules with protective potential,
uch as hesperidin (antitumor) and friedelin (anti-inﬂammatory)
Tanaka et al., 1997; Ahmadi et al., 2008; Hosseinimehr et al., 2009;
ntonisamy et al., 2011; Sahu et al., 2013). Human lymphocytes
ere used for the experiment. We  examined the possible cytotoxic
nd genotoxic effects of C. latipes Hex extract using double ﬂuo-
escein diacetate/ethidium bromide staining (FDA/EtBr) and the
omet assay, respectively. The viability of the cells after exposure
o the Hex extract (25, 35, and 50 g/ml) was greater than 70%
Fig. 1A), indicating that those doses were not cytotoxic. The posi-
ive control treated with EMS  caused signiﬁcant (p < 0.001). A clear
nd statistically signiﬁcant increase in DNA migration was  found in
ells exposed to extracts compared (p < 0.001) tail length (Fig. 1B).
he genotoxic effects determined by the Comet assay displayed a
ose-dependent response.iscussion
The evaluation of toxicity or protective effects of various
pecies used in traditional medicine is essential, and is increasinglyreceiving attention for their possible application in diseases such as
cancer (Moreira et al., 2014). This study reports the chemical com-
position of various organic extracts obtained from C. latipes leaves
and their in vitro antitumor activities (cytotoxic and genotoxic). The
presence of beta-amyrin, friedelin and friedolan-3-ol is consistent
with compounds commonly isolated from other species of the same
genus (Reyes-Chilpa et al., 2004; Teixeira et al., 2006; Mangas Marín
et al., 2008; Ribeiro et al., 2011). However, in the present study, we
successfully isolated and identiﬁed the presence of hesperidin in C.
latipes, which represents the ﬁrst report of this molecule from the
genus Clusia.  The presence of hesperidin may  justify the use of C.
latipes in traditional medicine and skin care, because this ﬂavone
has been shown to inhibit lesions of atopic dermatitis and the eleva-
tion of IgE in plasma of NC/Nga mice (Nagashio et al., 2013), as well
as to stimulate epidermal proliferation in normal mouse skin (Hou
et al., 2012). However, hesperedin also has anti-proliferative effects
in tumor cells, including breast cancer (Natarajan et al., 2011) and
colon cancer (Park et al., 2008). In addition, the hesperidin dis-
played cytotoxic effects on cell lines that show drug resistance,
which was related to the ABC transporter function (Bailón-Moscoso
et al., 2014). In the present study, the observed anti-proliferative
effect of the extracts on selected cancer cells could be attributed
to the presence of hesperidin, as well as the two triterpenes iso-
lated, friedelin (1) and friedolan-3-ol (2). In similar studies, it has
been observed that both friedelin and friedolan-3-ol have cyto-
toxic activity in other cell lines (Hela and CEM-SS), with IC50 values
between 3.5 g/ml and 11.8 g/ml (Utami et al., 2013).
Contrary to expectations, the C. latipes Hex extract induced
a signiﬁcant increase (p < 0.001) in DNA damage in lymphocytes
exposed to the concentrations used in this study. Because the
potential chemical or metabolic interactions of the phytometabo-
lites from the extracts with the oxidative cell machinery may
produce reactive oxygen species, we  suggest that the tested phy-
tometabolites could lead to the formation of free radicals. These
free radicals are capable of inducing DNA strand breaks, which were
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Further studies are needed to corroborate the cytotoxic and
enotoxic effects of this mixture and to provide a molecular
echanistic foundation of these effects prior to any potential anti-
eoplastic use.
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